
Recombinant Tropoelastin for Research and Development
20.11.2025

At matrihealth, we are committed to advancing elastin biotechnology. Today, we’re placing the spotlight on a new key component in our R&D portfolio: recombinant human tropoelastin.
Why Tropoelastin Matters
- Tropoelastin is the monomeric precursor to elastin—essential for studying elastin maturation, crosslinking, and the formation of functional elastin fibers.
- Our TROPOelastin is tag-free (no N- or C-terminal fusions and no signal sequences) and free from host cell proteins, ensuring the highest level of purity.
- Human tropoelastin Isoform 2 (UniProt P15502-2), with a mean molecular weight of approximately 60 kDa, comprises all biologically relevant domains and supports the development of elastin-inspired biomaterials.
- Production takes place entirely in Germany, through a trusted local partner under full process and quality oversight from matrihealth
With TROPOelastin, we are strengthening our mission to unlock the potential of elastin across research and biomedical innovation.
Learn more: -> Tropoelastin
Award for innovative strength: Our company receives the BSFZ seal of approval
30.10.2025
We are pleased to announce that our company has been awarded the BSFZ seal by the Research Allowance Certification Agency (BSFZ).
This seal officially confirms that we carry out recognized research and development (R&D) projects that meet the criteria of the Research Allowance Act (FZulG).
The BSFZ seal recognizes our innovative capabilities and research focus. It shows that we are actively working to develop new technological solutions and drive progress in our field.
We are proud of this recognition and would like to thank our entire team for their commitment, creativity, and dedication, which have contributed to this success.
➡️ For more information on the research allowance and the certification body, please visit www.bescheinigung-forschungszulage.de/forschung-und-entwicklung-im-rampenlicht.

We will be exhibiting at the SEPAWA® CONGRESS 2025 in Berlin!
08.10.2025
From October 15 to 17, 2025, we will be exhibiting alongside our distribution partner Julius Hoesch GmbH & Co. KG at SEPAWA® CONGRESS in Berlin—one of Europe's most important trade fairs for the detergent, cosmetics, and perfume industry.
Visit us at the fair and learn more about our matripure®, which offers innovative solutions for cosmetic applications. We look forward to showing you the versatile applications of our product and discussing new projects with you.
📍 Ort: Estrel Congress Center, Berlin
📅 Datum: 15.–17. Oktober 2025
We are looking forward to seu you in Berlin!

DGBM 2025 - Dresden
07.10.2025
We are excited to support the 31st Annual Meeting of the Deutsche Gesellschaft für Biomaterialien e.V. (German Society for Biomaterials, DGBM), taking place October 9–11, 2025, at Center for Regenerative Therapies, Dresden University of Technology.
Having already participated last year, we are thrilled about the collaborations that have emerged since then. This year, we are especially looking forward to reconnecting with the community, following up on exciting ongoing projects, discovering new ones, and presenting our new R&D product portfolio. We look forward to discussing innovative applications for elastin-based technologies together with researchers.
At matrihealth, our focus on elastin technologies drives innovation in biomaterials, tissue engineering, and regenerative medicine.
We can’t wait for inspiring talks, meaningful discussions, and fresh ideas.

Successful financing round: We are entering the next phase of growth
25.09.2025
We at matrihealth have reached an important milestone: our financing round has been successfully completed. With this capital, we are further expanding our production capacities in Halle (Saale) and preparing to enter the food market.
Since our founding as a Fraunhofer spin-off, we have pursued a clear goal: to make high-purity elastin industrially viable. In recent years, we have made great strides with new products, our own production facility, and strong partnerships.
“The successful financing round confirms our investors' confidence in our technology and our team. Now we can enter the next phase of growth,” says our CTO Tobias Hedtke.
Today, our portfolio already includes eleven elastin products – from matripure® as a cosmetic raw material to special applications in research, medicine, and, in the future, the food sector.
Elastin is a unique structural protein that enables elasticity and resilience in the human body. With our work, we are laying the foundation for harnessing this potential in a wide variety of applications—from skin care and wound healing to functional foods and tissue replacement.
We are convinced that the best is yet to come—and we look forward to continuing on this path together with our partners.

The matrihealth-founderteam: Dr. Marco Götze, Dr. Christian Schmelzer, Tobias Hedtke and Dirk Schuster (left to right) are delighted with the successful financing round. © Fraunhofer IMWS
Time for something new! - We are opening our laboratories and expanding our product portfolio in the R&D sector.
10.07.2025
We are pleased to introduce three new products that meet the actual research needs in the fields of biomaterials, release studies, and cross-linking systems:
🧬 TROPOelastin
Full-length recombinant human tropoelastin (isoform 2, UniProt: P15502-2)
→ manufactured in Germany by a local partner under full quality control
→ available from 01. September 2025 – pre-order now!
🧪 matritrace-R
Rhodamine-labeled elastin for easy tracking in biomaterial systems, release studies, and tissue integration.
⚗️ ELAMIN+
Amino acid-enriched elastin for tunable crosslinking, hydrogel design, and next-generation biomaterials.
These innovations are the result of collaborative development, specific customer needs, and internal R&D—all driven by a deep understanding of the material properties of elastin. These products are now part of our standard offering and can support your research!

We're in! Our start-up is presenting high-purity elastin at CosmeticBusiness 2025.
02.06.2025
A big stage for young ideas! We are thrilled to be participating as a start-up at CosmeticBusiness 2025 in Munich! On June 4 and 5, we will be presenting our innovation—matripure®, high-purity elastin for the next generation of effective skin care products—at the MOC. Launched in March and now on the big stage.
Our mission: to rethink cosmetics – with ingredients that are uncompromisingly pure, effective, and scientifically sound. Our elastin supports the skin's natural elasticity and offers exciting possibilities for modern formulations in the anti-aging sector.
Come by, get to know us, and discover what drives our young team. We look forward to inspiring conversations and new collaborations!
Let’s shape the future of beauty – together at CosmeticBusiness 2025!

Science meets companies 2025
15.05.2025
Every year again... After we were able to gain many new members for our team at last year's Sciencemeetscompanies, it was clear to us that we would be back this year!
We want to continue to grow and are looking for
- student assistants
- chemical laboratory assistants
- technical assistants
- Students with a bachelor's degree in the fields of chemistry
biochemistry or engineering
If you are interested in getting to know us, visit us at Sciencemeetscompanies 2025 on 15.05.2025 at the Biozentrum on the Weinbergcampus here in Halle. We look forward to exciting conversations and as many interested students as possible!
More information about the event:
https://sfi-halle.de/angebote/sciencemeetscompanies/aktuell/

In-cosmetics Global 2025 - Amsterdam
02.04.2025
The trade fair season is starting and we are right in the middle of it!
Together with our partner Deutsche Lanolin Gesellschaft GmbH & Co KG, we are looking forward to presenting our latest product matripure® for cosmetic applications at this year's in-cosmetics Global in Amsterdam from 8 - 10 April. The in-cosmetics is the leading trade fair for ingredients for cosmetic products and therefore the perfect place for Elastin! #
Visit us in hall 3 booth 3A91! We are looking forward to exciting conversations!
More information:
https://www.in-cosmetics.com/global/en-gb.html

Elastin for Cosmetics
19.02.2025
The matrihealth GmbH announces the successful qualification of its soluble elastin hydrolyzate matripure® for use in cosmetic products. This innovative ingredient provides cosmetic manufacturers with a natural source of elastin for the formulation of high-quality skincare products.
Elastin is a naturally occurring structural protein that plays a crucial role in maintaining skin elasticity and firmness. Over time, elastin is damaged by the natural aging process and external factors such as UV radiation, and the body is unable to regenerate it. Due to its unique properties, elastin is becoming an increasingly valuable ingredient in cosmetics, particularly in skincare formulations for dry and mature skin.
“With matripure®, we offer cosmetic manufacturers a high-quality elastin hydrolyzate made in Germany, ideal for premium skincare formulations. By managing the entire production process inhouse, from raw material selection to the final product, we ensure the highest quality standards
while remaining flexible to meet individual customer needs,” says Dr. Marco Götze, Managing Director of matrihealth GmbH.
matripure® is easy to integrate into water-containing formulations, has excellent water-binding capacity, and is optimized for effective performance on the skin. matripure® will be available to cosmetic manufacturers starting at the end of March.

EEM 2024
04.11.2024
Last week, the European Elastin Meeting EEM 2024 (https://elastin2024.sciencesconf.org/resource/page/id/3) took place in Reims and we were there for the first time as a start-up. The organizing team around Laurent Debelle from the University of Reims Champagne Ardenne put together a great lecture program around our favorite protein elastin, from elastogenesis to the application of elastin as part of biomaterials. We had the opportunity to introduce ourselves to the elastin community for the first time and gained exciting insights and new opportunities for cooperation in many discussions. It was an all-round successful event and we look forward to coming back next time!

© University of Reims Champagne Ardenne, France
Pharmatec 2024
20.09.2024
PHARMATEC 2024 (22.10. - 23.10.2024) will take place for the first time this year at the Biozentrum on the Weinbergcampus in Halle. The conference offers the opportunity to network with the most important companies and research institutions from the pharmaceutical and biotech sector from Saxony-Anhalt and to gain exciting insights from the fields of “Innovative Active Ingredient Systems”, “Dental Research” and “Service Providers and Suppliers for the Pharmaceutical and Healthcare System”. As matrihealth, we will of course not miss out on this and will be presenting the diverse application possibilities of elastin.
More informationen: https://www.pharmatec-halle.de/

© Fraunhofer-Gesellschaft e.V., München
DGBM-Annual Meeting 2024
03.09.2024
We are delighted to be attending the annual meeting of the German Society for Biomaterials (DGBM) for the first time this year. The conference will take place from 10.10. to 12.10.24 in Berlin. We will be represented with a stand and look forward to many interesting discussions and insights into current research.
More information at: https://dgbm-kongress.de/

© DGBM
matrihealth GmbH receives seed funding for the industrial production of elastin
03.06.2024
We are very pleased to announce that we have successfully completed our seed funding! Two private investors and the founding shareholder Fraunhofer Society have provided us with a seven-digit investment sum to enable the industrial production of elastin for the cosmetics, food and medical device markets. This will enable matrihealth GmbH to offer high-purity elastin in these market segments for the first time. We would like to thank you for the trust you have placed in us and look forward to getting off to a flying start!
Click here for the official press release:

The matrihealth founding team: Dirk Schuster, Dr. Marco Götze, Dr. Christian Schmelzer and Tobias Hedtke (from left to right). © Fraunhofer IMWS
Science meets companies 2024
16.05.2024
Time to grow! We are looking for new colleagues who want to support us on our exciting journey! To make us a little better known, we are looking forward to participating in this year's Sciencemeetscompanies 2024 at the Weinbergcampus in Halle. We are looking forward to exciting discussions and as many interested students as possible!
More information about the event:

matrihealth meets BACB
04.07.2023
the Business Angels Club Berlin Brandenburg e.V. invited us to their Pitch Day on 04.07. at the Bürgschaftsbank Berlin-Brandenburg to present our start-up together with 7 other start-ups in front of the members and guests of the BACB! It was a great evening with good conversations in a pleasant atmosphere. We are also very proud to have received the award for the best pitch!

We are INVEST-eligible!
25.05.2023
matrihealth is eligible for funding under the INVEST funding measure of the German Federal Ministry for Economic Affairs and Climate Action! The program subsidizes venture capital invested by private investors in young and innovative companies like matrihealth. Request more information about our company at info@matrihealth.com!

We are in!
23.05.2023
We have another reason to be happy! We have applied for the participation at the Investor Days Thuringia 2023 in Erfurt, and could convince the selection committee! We are now allowed to present our ideas and visions to potential investors on 14.06. and 15.06. together with 39 other start-ups! We are very much looking forward to it and an exciting exchange!

matrihealth on Tour!
27.04.2023
We are starting to like it in Munich! We had the opportunity to present our startup at the 3rd Occident Pitch Event of the Occident Group! It was an exciting evening with great start-ups and many conversations. Many thanks to the Occident Group and univations GmbH from Halle for letting us participate!

matrihealth is now Member of the Life Science Cluster Sachsen Anhalt
02.04.2023
We are now an official member of the Life-Science-Cluster Saxony-Anhalt. The Life-Science-Cluster sees itself as a network and interest group for the strengthening and networking of companies and research institutions in the fields of biotechnology, pharmacy as well as medicine and health in Saxony-Anhalt and Central Germany.
https://cluster-lifescience.de/

matrihealth on Tour!
29.03.2023
We are once again on the road in terms of investor search and are happy to be part of the Start Up Investor Days "4 Investors" in Munich today! The event is hosted by the four major non-university research institutions of the Max Planck Society, the Helmholtz Association, the Leibnitz Association and the Fraunhofer Society and only a limited number of spin-offs from these research institutions are allowed to present themselves to potential investors. We are looking forward to being there!

ELMA is here!
06.02.2023
We are very excited to introduce our first commercial product today! With our ELMA, methacylated elastin will soon be available for 3D printing for the first time! As an essential component of the extracellular matrix of all elastic tissues, our ELMA enables the production of artificial tissues by bioprinting!

matrihealth on tour!
15.02.2023
We are pleased to be present for the first time this year at the annual ESAO Symposium on Artificial Organs and Tissue Engineering. The symposium will take place in Wittenberg, Germany, from Feb. 15 to Feb. 18, 23. We are especially looking forward to present our ELMA, methacrylated elastin for biorprinting, for the first time. We are looking forward to exciting discussions and interesting insights into current research.
More information: https://www.esao.org/

© ESAO
matriheal goes matrihealth
04.10.2022

On 04.10.2022 it was finally time, after almost 2 years of preparation, the notary appointment took place in Halle (Saale) and we could finally found the matrihealth GmbH! Many thanks to all who accompanied and supported us on the exciting way! We are looking forward to the coming time and to take the next steps together with you!
We are in!
23.11.2022
On November 23, 2022, the Fraunhofer Investment Forum 2022 will take place digitally and on-site in Munich. Together with other exciting spin-offs of the Fraunhofer Gesellschaft, we will have the opportunity to pitch to interested investors and hold exciting discussions. We are looking forward to it!

Become a part of our story!
10.04.2022
We are looking for investors and supporters with experience in the MedTech industry:
// Sales cooperation
// Strategic partnerships
// Partners for approval and certification

© 2022
© Fraunhofer IMWS / Michael Deutsch
© 2025
